A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN

Gynecologic Oncology

Volumn 63, Issue 3, 1996, Pages 337-344

  Brewer, Cheryl A ^a   Liao, Shu Y ^b,f   Wilczynski, Sharon P ^c   Pastorekova, Silvia ^d   Pastorek, Jan ^d   Zavada, Jan ^e   Kurosaki, Tom ^f   Manetta, Alberto ^a   Berman, Michael L ^a   DiSaia, Philip J ^a   Stanbridge, Eric J ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d INSTITUTE OF VIROLOGY   (Slovakia)

^e INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; DNA; MYC PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRID CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0030561349     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0333     Document Type: Article

References (30)

1. 1. Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J. P., Zelnik, V., Opavsky, R., Zat'ovicova, M., Liao, S., Portetelle, D., Stanbridge, E. J., et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment, Oncogene 9(10), 2877-2888 (1994).
2. 2. Zavada, J., Zavadova, Z., Pastorekova, S., Ciampor, F., Pastorek, J., and Zelnik, V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int. J. Cancer 54, 268 (1993).
3. 3. Liao, S. Y., Brewer, C. A., Zavada, J., Pastorek, J., Pastorekova, S., Manneta, A., Berman, M. L., DiSaia, P. J., and Stanbridge, E. J. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas, Am. J. Pathol. 145(3), 598-609 (1994).
4. 4. Howley, P. M. Role of the human papillomaviruses in human cancer, Cancer Res. 51, 5019s-5022s (1991).
5. 5. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science 248, 76-79 (1990).
6. 6. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. The HPV-16 E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53, Cell 75(3), 495-505 (1993).
7. 7. Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., Stanton, C. K., and Manos, M. M. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia, J. Natl. Cancer Inst. 85(12), 958-964 (1993).
8. 8. Reeves, W. C., Rawles, W. E., and Brinton, L. A. Epidemiology of genital papillomaviruses and cervical cancer, Rev. Infect. Dis. 11(3), 426-439 (1989).
9. 9. Hampton, G. M., Penny, L. A., Baergen, A., Larson, A., Brewer, C., Liao, S., Busby-Earle, R. M. C., Williams, A. W. R., Steel, C. M., Bird, C. C., Stanbridge, E. J., and Evans, G. A. Loss of heterozygosity in cervical cancers: Subchromosomal localization of a putative tumor suppressor gene to 11q22-q24, Proc. Natl Acad. Sci. USA 91(15), 6953-6957 (1994).
10. 10. Riou, G. F., Bourhis, J., and Le, M. G. The c-myc proto-oncogene in invasive carcinoma of the uterine cervix: Clinical relevance of overexpression in early stages of the cancer, Anticancer Res. 10(5A), 1225-1231 (1990).
11. 11. Tanimoto, H., Nagai, N., Fujimoto, H., Ohta, S., and Ohama, K. Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas, Acta Obstet Gynecol. Jpn. 44(5), 566-570 (1992).
12. 12. Pinion, S. B., Kennedy, J. H., Miller, R. W., and Maclean, A. B. Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of the cervix, Lancet 337(8745), 819-820 (1991).
13. 13. Symonds, R. P., Habeshaw, T., Paul, J., Kerr, D. J., Darling, A., Burnett, R. A., Sotsiou, F., Linardopoulos, S., and Spandidos, D. A. No correlation between ras, c-myc, and c-jun proto-oncogene expression and prognosis in advanced cervical cancer, Eur. J. Cancer 28A(10), 1615-1617 (1992).
14. 14. Nurnberg, W., Artuc, M., Vorbrueggen, G., Kalkbrenner, F., Muelling, K., Czarnetzki, B. M., and Schadendorf, D. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter, Br. J. Cancer 71(5), 1018-1024 (1995).
15. 15. Der, C. J., and Stanbridge, E. J. A tumor-specific membrane phosphoprotein marker in human cell hybrids, Cell 26, 429 (1981).
16. 16. Latham, K. M., and Stanbridge, E. J. Identification of the HeLa tumor-associated antigen, p-75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation, Proc. Natl. Acad. Sci. USA 87, 1263-1267 (1990).
17. 17. Latham, K. M., and Stanbridge, E. J. Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa × fibroblast cell hybrids, Cancer Res. 52, 616-622 (1992).
18. 18. Street, D., and Delgado, G. The role of p53 and HPV in cervical cancer, Gynecol. Oncol. 58, 289-294 (1995).
19. 19. Busby-Earl, R. M., Steel, C. M., Williams, A. R., Cohen, B., and Bird, C. C. p53 mutations in cervical carcinogenesis - Low frequency and lack of correlation with human papillomavirus status, Br. J. Cancer 69(4), 732-737 (1994).
20. 20. Park, D. J., Wilczynski, S. P., Paquette, R. L., Miller, C., and Koeffler, H. P. p53 mutations in HPV-negative cervical carcinoma, Oncogene 9(1), 205-210 (1994).
21. 21. Monk, B. J., Cook, N., Ahn, C., Vasilev, S. A., Berman, M. L., and Wilczynski, S. P. Comparison of the polymerase chain reaction and Southern blot analysis in detecting and typing human papilloma-virus deoxyribonucleic acid in tumors of the lower female genital tract, Diagn. Mol. Pathol. 3(4), 283-291 (1994).
22. 22. Si, J. Y., Lee, K., Han, R., Zhang, W., Tan, B. B., Song, Gx, Liu, S., Chen, L. F., Zhao, W. M., Jia, L. P., et al. A research for the relationship between human papillomavirus and human uterine cervical carcinoma. I. The identification of viral genome and subgenomic sequences in biopsies of Chinese patients, J. Cancer Res. Clin. Oncol. 117(5), 454-459 (1991).
23. 23. Nagai, N. Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related studies - Analysis of HPV types 16, 18 E6/E7 gene mRNA, Acta Obstet. Gynecol. Jpn. 42(8), 823-833 (1990).
24. 24. Stanbridge, E. J. Suppression of malignancy in human cells, Nature 260, 17-20 (1994).
25. 25. Stanbridge, E. J. Human tumor suppressor genes, Annu. Rev. Genet. 24, 615-657 (1990).
26. 26. Anderson, M. J., and Stanbridge, E. J. Tumor suppressor genes studied by cell hybridization and chromosome transfer, FASEB J. 7, 826-833 (1993).
27. 27. DeBritton, R. C., Hildesheim, A., DeLao, S. L., Brinton, L. A., Sathya, P., and Reeves, W. C. Human papillomaviruses and other influences on survival from cervical cancer in Panama, Obstet. Gynecol. 81, 19-24 (1993).
28. 28. Franco, E. L. Prognostic value of human papillomaviruses in the survival of cervical cancer patients: an overview of the evidence, Cancer Epidemiol. Biomed. Prev. 1(6) 499-504 (1992).
29. 29. Petrov, S. V., Mazurenko, N. M., Sukhova, N. M., Moroz, I. P., Katsenel'son, V. M., Raikhlin, N. T., and Kiselev, F. L. Arkhiv Patlolgii 56(4), 22-31 (1994).
30. 30. Delgado, G., Bundy, B., Zaino, R., Sevin, B. U., Creasman, W. T., and Major, F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study, Gynecol. Oncol. 38, 352-357 (1990).